Umbelliferone aminoalkyl derivatives as inhibitors of human oxidosqualene-lanosterol cyclase

References

• ES Istvan, and J Deisenhofer. (2001). Structural mechanism for statin inhibition of HMG-CoA reductase. Science 292:1160–1164.
   PubMed Web of Science ®Google Scholar
• A Chugh, A Ray, and JB Gupta. (2003). Squalene epoxidase as hypocholesterolemic drug target revisited. Prog Lipid Res 42:37–50.
   PubMed Web of Science ®Google Scholar
• OH Morand, JD Aebi, H Dehmlow, YH Ji, N Gains, H Langsfeld, and J Himber. (1997). Ro48-8071, a new 2,3-oxidosqualene:lanosterol cyclase inhibitor lowering plasma cholesterol in hamsters, squirrel monkeys, and minipigs: comparison to simvastatin. J Lipid Res 38:373–390.
   PubMed Web of Science ®Google Scholar
• H Dehmlow, JD Aebi, S Jolidon, YH Ji, EM von der Mark, J Himber, and OH Morand. (2003). Synthesis and structure-activity studies of novel orally active non-terpenoic 2,3-oxidosqualene cyclase inhibitors. J Med Chem 46:3354–3370.
   PubMed Web of Science ®Google Scholar
• MW Huff, and DE Telford. (2005). Lords of the rings – the mechanism for oxidosqualene:lanosterol cyclase becomes crystal clear. Trends Pharmacol Sci 26:335–340.
   PubMed Web of Science ®Google Scholar
• AH Rowe, CA Argmann, JY Edwards, CG Sawyez, OH Morand, RA Hegele, and MW Huff. (2003). Enhanced synthesis of the oxysterol 24(S),25-epoxycholesterol in macrophages by inhibitors of 2,3-oxidosqualene:lanosterol cyclase: a novel mechanism for the attenuation of foam cell formation. Circ Res 93:717–725.
   PubMed Web of Science ®Google Scholar
• R Thoma, T Schulz-Gasch, B D'Arcy, J Benz, J Aebi, H Dehmlow, M Hennig, M Stihle, and A Ruf. (2004). Insight into steroid scaffold formation from the structure of human oxidosqualene cyclase. Nature 432:118–122.
   PubMed Web of Science ®Google Scholar
• S Oliaro-Bosso, F Viola, SPT Matsuda, G Cravotto, S Tagliapietra, and G Balliano. (2004). Umbelliferone aminoalkyl derivatives as inhibitors of oxidosqualene cyclases from Saccharomyces cerevisiae, Trypanosoma cruzi and Pneumocystis carinii. Lipids 39:1007–1012.
   PubMed Web of Science ®Google Scholar
• S Oliaro-Bosso, F Viola, S Taramino, S Tagliapietra, A Barge, G Cravotto, and G Balliano. (2007). Inhibitory effect of umbelliferone aminoalkyl derivatives on oxidosqualene cyclases from Saccharomyces cerevisiae, Trypanosoma cruzi, Pneumocystis carinii, Homo sapiens and Arabidopsis thaliana: a structure-activity study. Chem Med Chem 2:226–233.
   Web of Science ®Google Scholar
• M Ceruti, G Balliano, F Viola, L Cattel, N Gerst, and F Schuber. (1987). Synthesis and biological activity of azasqualenes, bis-azasqualenes and derivatives. Eur J Med Chem 22:199–208.
   Web of Science ®Google Scholar
• G Cravotto, G Balliano, S Tagliapietra, S Oliaro-Bosso, and GM Nano. (2004). Novel squalene-hopene cyclase inhibitors derived from hydroxycoumarins and hydroxyacetophenones. Chem Pharm Bull 52:1171–1174.
   PubMed Web of Science ®Google Scholar
• G Cravotto, G Balliano, S Tagliapietra, G Palmisano, and A Penoni. (2004). Umbelliferone aminoalkyl derivatives, a new class of squalene-hopene cyclase inhibitors. Eur J Med Chem 39:917–924.
   PubMed Web of Science ®Google Scholar
• M Ceruti, G Balliano, F Rocco, P Milla, S Arpicco, L Cattel, and F Viola. (2001). Vinyl sulfide derivatives of truncated oxidosqualene as selective inhibitors of oxidosqualene and squalene hopene cyclases. Lipids 36:629–636.
   PubMed Web of Science ®Google Scholar
• G Popják. Steroids and terpenoid. In. RB Clayton, editor. Methods in enzymology. Vol. XV New York: Academic Press; (1969) p 438–443.
   Google Scholar
• RB Field, CE Holmund, and NF Whittake. (1979). The effects of the hypocholesteremic compound 3 beta-(beta-dimethylaminoethoxy)-androst-5-en-17-one on the sterol and steryl ester composition of Saccharomyces cerevisiae. Lipids 14:741–747.
   PubMed Web of Science ®Google Scholar
• EJ Corey, SPT Matsuda, CH Baker, AY Ting, and H Cheng. (1996). Molecular cloning of a Schizosaccharomyces pombe cDNA encoding lanosterol synthase and investigation of conserved tryptophan residues. Biochem Biophys Res Commun 219:327–331.
   PubMed Web of Science ®Google Scholar
• FM Ausubel, R Brent, RE Kingston, DD Moore, JD Seidman, J Smith, and K Struhl. Current protocols in molecular biology. NY: Wiley-Interscience; (1999).
   Google Scholar
• GL Peterson. (1977). A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83:346–356.
   PubMed Web of Science ®Google Scholar
• RG Duggleby. (1981). A nonlinear regression program for small computers. Anal Biochem 110:9–18.
   PubMed Web of Science ®Google Scholar
• BE Chan, and BR Knowles. (1976). A solvent system for delipidation of plasma or serum without protein precipitation. J Lipid Res 17:176–181.
   PubMed Web of Science ®Google Scholar
• HM Berman, J Westbrook, Z Feng, G Gilliland, TN Bhat, H Weissig, IN Shindyalov, and PE Bourne. (2000). The protein data bank. Nucleic Acids Res 28:235–242.
   PubMed Web of Science ®Google Scholar
• P Labute, C Williams, M Feher, E Sourial, and JM Schmidt. (2001). Flexible alignment of small molecules. J Med Chem 44:1483–1490.
   PubMed Web of Science ®Google Scholar
• G Ermondi, M Lorenti, and G Caron. (2004). Contribution of ionization and lipophilicity to drug binding to albumin: a preliminary step toward biodistribution prediction. J Med Chem 47:3949–3961.
   PubMed Web of Science ®Google Scholar
• TA Halgren. (1996). Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J Comput Chem 17:490–519.
   Web of Science ®Google Scholar
• IT Christensen, and FS Jorgensen. (1997). Molecular mechanics calculations of proteins. Comparison of different energy minimization strategies. J Biomol Struct Dyn 5:473–488.
   Web of Science ®Google Scholar
• F Viola, P Brusa, G Balliano, M Ceruti, O Boutaud, F Schuber, and L Cattel. (1995). Inhibition of 2,3-oxidosqualene cyclase and sterol biosynthesis by 10- and 19-azasqualene derivatives. Biochem Pharmacol 50:787–796.
   PubMed Web of Science ®Google Scholar
• U Galli, S Oliaro-Bosso, S Taramino, S Venegoni, E Pastore, GC Tron, G Balliano, F Viola, and G Sorba. (2007). Design, synthesis and biological evaluation of new (2E,6E)-10-(dimethylamino)-3,7-dimethyl-2,6-decadien-1-ol ethers as inhibitors of human and Trypanosoma cruzi oxidosqualene cyclase. Biorg Med Chem Letters 17:220–224.
   PubMed Web of Science ®Google Scholar
• CH Baker, SPT Matsuda, DR Liu, and EJ Corey. (1995). Molecular cloning of the human gene encoding lanosterol synthase from a liver cDNA library. Biochem Biophys Res Commun 213:154–160.
   PubMed Web of Science ®Google Scholar
• CK Sung, M Shibuya, U Sankawa, and Y Ebizuka. (1995). Molecular cloning of cDNA encoding human lanosterol synthase. Biol Pharm Bull 18:1459–1461.
   PubMed Web of Science ®Google Scholar
• E Roessler, L Mittaz, Y Du, HS Scott, J Chang, C Rossier, M Guipponi, SPT Matsuda, M Muenke, and SE Antonarakis. (1999). Structure of the human lanosterol synthase gene and its analysis as a candidate for holoprosencephaly (HPE1). Hum Genet 105:489–495.
   PubMed Web of Science ®Google Scholar
• F Viola, M Ceruti, G Balliano, O Caputo, and L Cattel. (1990). 22,23-epoxy-2-aza-2,3-dihydrosqualene derivatives: potent new inhibitors of squalene 2,3-oxide-lanosterol cyclase. Il Farmaco 45:965–978.
   PubMedGoogle Scholar
• A Lenhart, DJ Reinert, JD Aebi, H Dehmlow, OH Morand, and GE Schulz. (2003). Binding structures and potencies of OSC inhibitors with the homologous squalene-hopene cyclase. J Med Chem 46:2083–2092.
   PubMed Web of Science ®Google Scholar
• DJ Reinert, G Balliano, and GE Schulz. (2004). Conversion of squalene to the pentacarbocyclic hopene. Chem Biol 11:121–126.
   PubMedGoogle Scholar